Japan’s economy contracted in the first quarter of the year by less than initially estimated on better inventory and consumption figures, while still backing...
Brokerage firm Nuvama on Thursday, March 13, cut its target price on Zydus Lifesciences by over 16%.The brokerage has maintained its "reduce" rating on...